Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-030568
Filing Date
2020-02-11
Accepted
2020-02-11 07:01:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d832850d424b5.htm 424B5 481960
2 GRAPHIC g832850g05e18.jpg GRAPHIC 45297
3 GRAPHIC g832850g61v41.jpg GRAPHIC 49505
  Complete submission text file 0001193125-20-030568.txt   603728
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228661 | Film No.: 20593862
SIC: 2834 Pharmaceutical Preparations